161Tb-DOTA-LM3 | Interleukin Related interleukin-related.com

Product Name :
161Tb-DOTA-LM3

Search keywords :
DOTA-LM3

drugId :
null

Target Vo:
Somatostatin receptor 2

Target Vo Short Name :
SSTR2

Moa_Name:
Somatostatin receptor 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Hospital Basel

Active Company_Name :
University Hospital Basel

Active Indication_Name:
Neuroendocrine Tumors

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cdk2 Antibody
RhoA Antibody
nNOS Antibody: nNOS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 161 kDa, targeting to nNOS. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts